Transferrins and defence against infection.
Brock
J H
JH
Mainou-Fowler
T
T
McGregor
S J
SJ
D001692:Biological Transport; D002614:Chelating Agents / Q000627:therapeutic use; D004198:Disease Susceptibility; D006801:Humans; D007239:Infections / Q000276:immunology / Q000378:metabolism*; D007501:Iron / Q000378:metabolism; D000090463:Iron Deficiencies; D007781:Lactoferrin / Q000172:deficiency / Q000502:physiology; D008214:Lymphocytes / Q000276:immunology / Q000378:metabolism; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D011485:Protein Binding; D014168:Transferrin / Q000172:deficiency / Q000502:physiology*
D002614:Chelating Agents; D014168:Transferrin; D007501:Iron; D007781:Lactoferrin